NCT06398977 Dapagliflozin Delays the Loss of Renal Function in Peritoneal Dialysis Patients Status RECRUITING Phase NA
NCT06383832 Effect of Dapagliflozin on Body Weight in Overweight Women Consuming Different Proportions of Carbohydrate Diet. Status COMPLETED Phase PHASE4
NCT06365541 The Efficacy and Safety of Dapagliflozin in Improving Heart Failure in Dialysis Patients Status RECRUITING Phase PHASE4
NCT06326034 Impact of Dapagliflozin as Add-on Therapy on Glycemic Status and Quality of Life in Type 2 Diabetic Patients Status COMPLETED Phase PHASE4
NCT06304857 CardioPROTECTion with Dapagliflozin in Breast Cancer Patients Treated with AnthrAcycline - PROTECTAA TRIAL Status RECRUITING Phase PHASE3
NCT06286878 Pleiotropic Effects of Dapagliflozin in Patients With Acute Coronary Syndromes Status RECRUITING Phase PHASE2/PHASE3
NCT06192108 A Study of Orforglipron (LY3502970) Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin Status COMPLETED Phase PHASE3
NCT06147518 To Compare the Safety and Efficacy of Dapagliflozin Plus Metformin Versus Sitagliptin Plus Metformin for Treatment of Diabetes in Patients With Compensated and Stable Decompensated Cirrhosis Status NOT_YET_RECRUITING Phase NA
NCT06127433 The Effect of Short-term Insulin Intensive Therapy Based on the Application of Insulin Pump and Real-time Dynamic Glucose Monitoring Technology on Reversing the Newly Diagnosed Type 2 Diabetes Status RECRUITING Phase PHASE4
NCT06111768 Sodium-Glucose Cotransporter-2 Inhibitor for Acute Cardiorenal Syndrome: A Feasibility Study Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06087835 Study to Investigate Efficacy, Safety, and Tolerability of Zibotentan/Dapagliflozin Compared to Dapagliflozin in Participants With Chronic Kidney Disease and High Proteinuria (ZENITH High Proteinuria) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05957887 Short and Intermediate Term Effect of Dapagliflozin on Left Ventricular Remodeling in Anterior STEMI Patients Status RECRUITING Phase PHASE3
NCT05944016 Phase 3 Clinical Trial with Dapagliflozin in Chronic Kidney Disease in Adolescents and Young Adult Patients Status RECRUITING Phase PHASE3
NCT05886088 Efficacy and Safety of LID104 in the Treatment of Type II Diabetes Mellitus Status NOT_YET_RECRUITING Phase PHASE3
NCT05849220 Dapagliflozin in Non Alcoholic Fatty Liver Disease Associated Cirrhosis and Its Role in Preventing Development of Chronic Kidney Disease. Status UNKNOWN Phase NA
NCT05848102 Dapagliflozin Effect on FunctiOnal Mitral Regurgitation and Myocardial Fibrosis (DEFORM) Status UNKNOWN Phase PHASE4
NCT05816733 Dapagliflozin Evaluation on Atrial Fibrillation Patients Followed Cox Maze IV Procedure Status RECRUITING Phase PHASE4
NCT05748925 Cardio Renal Effects of SGLT2 Inhibitors Among Lupus Nephritis Patients Status COMPLETED Phase PHASE4